Idoate, M., Ariz Galilea, M., Urbiola, A., Alonso-García, M., Machuca-Aguado, J., Ortiz de Solórzano, C., . . . Biscuola, M. (2025). Immune scenario identification combining multiplexed, quantitative, and advanced imaging analysis could be relevant in immunotherapy against glioblastoma and grade 4 astrocytoma.
Citación estilo ChicagoIdoate, Miguel-Ángel, Mikel Ariz Galilea, Ainhoa Urbiola, Miriam Alonso-García, Jesús Machuca-Aguado, Carlos Ortiz de Solórzano, Eloy Rivas-Infante, Rainiero Avila-Polo, y Michele Biscuola. Immune Scenario Identification Combining Multiplexed, Quantitative, and Advanced Imaging Analysis Could Be Relevant in Immunotherapy against Glioblastoma and Grade 4 Astrocytoma. 2025.
Cita MLAIdoate, Miguel-Ángel, et al. Immune Scenario Identification Combining Multiplexed, Quantitative, and Advanced Imaging Analysis Could Be Relevant in Immunotherapy against Glioblastoma and Grade 4 Astrocytoma. 2025.